Although not licensed as a drug, melatonin is widely sold as a nutriti
onal supplement in the USA for its purported sleep-promoting and antia
geing properties. In this article, we provide some guidelines for its
use in sleep disorders medicine. In brief, melatonin appears to promot
e sleep by producing corrective circadian phase shifts, thereby improv
ing the alignment of the endogenous sleep propensity rhythm with the d
esired sleep schedule. Melatonin may also have a direct soporific effe
ct, especially when administered during the day. We suggest that the d
irect soporific action results from the release of accumulated sleep d
rive by melatonin's attenuation of the circadian alerting signal. Mela
tonin has not been proven safe by the usual clinical trial criteria, b
ut to date no catastrophes have been related to its use. Also, there i
s little information about the safety and efficacy of chronic administ
ration.